The Fall of 23andMe: Genetic Testing's Rise & Fall

Genetic testing company, 23andMe, and it's founder Anne Wojiciki are on a mission to "revolutionise healthcare" - genotyping the world from just a single test tube of saliva...

With backing from Google and GSK, how did the once valued $6 Billion dollar biotech startup collapse to a penny stock that now risks being delisted from the NASDAQ?

Let's explore The Collapse of 23andMe....

Timestamps:
00:00 Prologue: The Collapse of 23andMe
01:23 NASDAQ Delisting
01:44 Genetic Testing, Explained
04:38 What Went Wrong?
06:09 Flawed Business Model
07:48 The Next Steps for 23andMe
09:31 Conclusion: The Beauty of DNA

#BEYOND #DNA #23andMe #genetictesting

"BEYOND, infinity" is a show that explores the future of science, health and tech.
Subscribe for more vids like these :)

--------------------------------
WHO AM I?
Hey, I'm Esh - a medical student, podcaster and video journalist exploring the future of science, health and tech.
I'm on a mission to tell stories that demonstrate why tech is so important for both our health and future.